XIth Eurasian Hematology-Oncology Congress - EHOC 2020

 

Myeloma
15:54

XIth Eurasian Hematology-Oncology Congress - EHOC 2020

MRD in Newly Diagnosed MM: MRI vs. PET/CT, RVD+/-ASCT, Dara+Len to Revert MRD+ to MRD-, Correlation Between Levels and Outcomes

FEATURING Evangelos Terpos
  • 6 views
  • January 15, 2021
14:53

XIth Eurasian Hematology-Oncology Congress - EHOC 2020

miRNAs in MM: Dysregulated miRNA Expression Cancer Cells, miR-221/222 Cluster in More Favorable Prognosis, miR-15a & miR-16 in Bone Disease

FEATURING Aristea-Maria Papanota
  • 9 views
  • January 12, 2021
23:52

XIth Eurasian Hematology-Oncology Congress - EHOC 2020

Decision Making in R/R MM: What Options to Consider for 1st Relapse in Disease not Refractory to Lenalidomide, First Relapse in Lenalidomide-Refractory Disease, or After 2+ Prior Therapies?

FEATURING Angelo Maiolino
  • 36 views
  • January 11, 2021
16:34

XIth Eurasian Hematology-Oncology Congress - EHOC 2020

Frontline MM Updates: What Are the Benefits of Long-Term, Continuous Therapy? Will D-VTd Increase CRR After Consolidation? How to Manage Newly Diagnosed Transplant Candidates?

FEATURING Maria-Victoria Mateos
  • 131 views
  • January 11, 2021
  • 1